Oral Treatment (Medical Not Surgical) for Fibroid Tumors and Associated Bleeding

An oral medication for the treatment of heavy menstrual bleeding due to uterine fibroids. Changes in fibroid and uterine size will also be evaluated by ultrasound.

Eligible participants are women who are:

  • between 18 and 49 years of age
  • in good general health
  • experiencing heavy menstrual bleeding (menorrhagia) from uterine fibroids
  • be willing to discontinue current hormonal treatments for the course of screening and up to six months of treatment.

Medical insurance is not required for study participation and compensation for time and travel is provided. To learn more about the study or if you’re interested in enrolling, please contact Alisha Lutat, Vanessa Lukas, or Carol Mack, PA-C at 202-293-1000 or
email us.